# Immunotherapy

mRNA’s New Frontier: MIT Breakthrough Signals an End to ‘Untreatable’ Solid Tumors

Researchers from MIT and MGH have developed a groundbreaking mRNA-based adjuvant that cleared solid tumors in aggressive animal models. By reprogramming dendritic cells to enhance T-cell responses, the study published in Nature Biotechnology offers a potential breakthrough for treating 'cold' tumors that are currently resistant to standard immunotherapy.